HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oreal Introduces Walgreens Shoppers To La Roche-Posay, Vichy Labs

This article was originally published in The Rose Sheet

Executive Summary

L’Oreal casts a wider net for its La Roche-Posay and Vichy Laboratoires brands, at one time available exclusively in European pharmacies, expanding to select Walgreens locations across the U.S. Brands will be supported by interactive kiosk technology to educate consumers and enhance the shopping experience.

You may also be interested in...



Walgreens Looks To Capitalize On “Expertise” Of British Retailer Boots

Walgreens looks to leverage private-label brands and know-how of British retailer Alliance Boots GMBH, in which it recently acquired a 45% stake. Walgreen’s increasing interest in private label “does not bode well for many of Walgreens' suppliers,” according to Euromonitor.

L'Oreal Banking On “Major” Product Launches In 2012 Second Half

L’Oreal will launch three major new fragrances that will help boost its cosmetics sales beyond the projected growth rate of the overall global cosmetics market this year, firm states in Aug. 29 earnings report. Net operating profit advanced 11.4% to $2.37 billion in first half.

In Brief

For the sixth year in a row, random testing shows members of the International Fragrance Association to be 100% compliant with ingredient safety standards established under the organization’s Code of Practice. More news in brief.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018248

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel